France’s top generic drug maker, Biogaran, could soon be sold to a British investment fund, raising new fears about the country’s control over vital medicines.
Via RFI
Read original article
France’s top generic drug maker, Biogaran, could soon be sold to a British investment fund, raising new fears about the country’s control over vital medicines.
Via RFI
Read original articleSite administrator for Haitian Globe
Comments (0)
Add a Comment
No comments yet